Uploaded August 2026 | Updated September 2026, 2 weeks ago

---

Moderna and Merck stocks surged Wednesday after the companies say its joint mRNA melanoma vaccine trial showed early promising results in Phase 3. The companies said the treatment reduced cancer from returning and spreading.

#news #science #cbcnews

The National is the flagship of @CBCNews showcasing award-winning journalism from across Canada and around the world. Led by Chief Correspondent Adrienne Arsenault, our team of trusted reporters helps you make sense of the world, wherever you are.

Subscribe to get the latest news daily, and watch live starting at 9 p.m. ET.
youtube.com/user/CBCTheNational?sub_confirmation=1

More from CBC News | cbc.ca/news